SC
ARWR icon

Sophrosyne Capital’s Arrowhead Research ARWR Stock Holding History

Sophrosyne Capital’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-35,458
Closed -$508K – 61
2014
Q2 		$508K Sell
35,458
-13,500
-28% -$177K 0.52% 38
2014
Q1 		$802K Sell
48,958
-91,900
-65% -$1.61M 0.7% 32
2013
Q4 		$1.53M Sell
140,858
-153,725
-52% -$1.23M 1.34% 23
2013
Q3 		$1.68M Buy
+294,583
New +$1.13M 1.11% 28

Other funds holding ARWR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sophrosyne Capital's ARWR Position: Q3 2014 in Review

Sophrosyne Capital sold out of Arrowhead Research (ARWR) in Q3 2014, closing a stake of 35,458 shares — an estimated $508K sold.

Sophrosyne Capital first reported a position in ARWR in Q3 2013 and held it in 4 quarters. The position peaked at $1.68M in Q3 2013. 110 funds tracked by Wall St. Rank hold ARWR as of Q3 2014.

  • Sophrosyne Capital reported no remaining Arrowhead Research position as of Q3 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 35,458 Arrowhead Research shares in Q3 2014, an estimated $508K.
  • Sophrosyne Capital first reported a position in Arrowhead Research in Q3 2013 and held it in 4 quarters.
  • Sophrosyne Capital's Arrowhead Research position peaked at $1.68M in Q3 2013.
  • 110 funds tracked by Wall St. Rank held Arrowhead Research as of Q3 2014.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.